Coronary artery disease remains the leading cause of death in the developed world. Over recent years, research has been focused on the development of diagnostic intravascular imaging techniques that enable assessment of plaque composition and morphology, and allow identification of vulnerable, high-risk lesions. Nevertheless recent studies of coronary atherosclerosis have shown that invasive modalities have a limited accuracy in detecting lesions that will progress and cause events, whilst histology-based studies also highlighted the limitations of invasive imaging in assessing plaque characteristics. To overcome these drawbacks, multimodality imaging has been proposed. Although it is apparent that coronary imaging with two or three imaging modalities is time consuming and is associated with a risk of complications, evidence from small clinical studies demonstrated that it provides incremental information about plaque pathology and biology and underscored the need to develop dual-probe hybrid imaging catheters that would enable complete and comprehensive assessment of plaque morphology. This paper reviews the current clinical evidence that supports the use of multimodality intravascular imaging in the study of atherosclerosis, summarizes the key findings of the first invasive imaging studies that utilize hybrid dual-probe catheters, and discusses the limitations of combined intravascular imaging that restrict its broad application in both the clinical and research arena.
Introduction
Coronary angiography has long been considered the gold standard imaging modality for the evaluation of coronary artery disease. Coronary angiography however, has significant limitations in the assessment of lesion pathology and biology. Whilst enabling twodimensional (2D) visualization of luminal silhouette, it does not permit the evaluation of the plaque characteristics, which appear to determine its natural course and vulnerability.
The in vivo assessment of plaque characteristics first became feasible in the beginning of nineties with the introduction of intravascular ultrasound (IVUS) imaging. The application of this technique in the clinical setting heightened our appreciation of the limitations of coronary angiography in assessing the severity of a lesion and plaque morphology, and emphasized the need to develop alternative imaging modalities for studying coronary plaque characteristics. Several intravascular imaging techniques have been developed over the past few years that have enhanced our understanding of atherosclerotic evolution. Some of these modalities have been validated and are currently part of daily clinical practice [e.g. optical coherence tomography (OCT), and near infrared spectroscopy (NIRS)], whilst others remain in the development phase and under pre-clinical evaluation (i.e. Raman spectroscopy, photoacoustic imaging, intravascular magnetic resonance imaging, near infrared fluorescence imaging, and fluorescence lifetime imaging). Histology-based and clinical studies have provided robust evidence about the clinical and research potential of the clinically applicable modalities but also revealed their limitations in the study of atherosclerosis (see Supplementary data online, Supplementary Data). To overcome the inherent drawbacks of the existing techniques, multimodality intravascular imaging was proposed in order to synergize their strengths for better assessment of plaque morphology and vulnerability ( Figure 1) . Today, several dualprobe catheters have been developed that enable combined intravascular imaging of plaque pathobiology. 1 In this review article, we present the evidence from clinical studies that supports the value of multimodality intravascular imaging in the study of atherosclerosis (see Supplementary data online, Table S1 ), summarize the key findings of the first human studies that evaluated the use of dual-probe catheters to assess plaque morphology, and discuss the future perspectives of multimodality imaging.
Multimodality imaging in the study of atherosclerosis: feasibility and current evidence Intravascular ultrasound and optical coherence tomographic imaging Sawada et al. were the first to suggest the combined use of RF-IVUS and OCT to assess plaque pathology, advocating that imaging with two imaging modalities with complementary strengths would enable more reliable evaluation of plaque morphology. 2 One hundred and six coronary plaques in 56 patients who underwent coronary angiography for stable angina were included in the analysis. The authors found significant discrepancies between RF-IVUS and OCT and concluded that both modalities are necessary for an accurate assessment of the phenotype of plaque. In particular, the moderate resolution of RF-IVUS did not permit accurate differentiation between TCFA and FA, whereas OCT often failed to characterize the superficial necrotic core component in vessels with a larger lumen, likely due to the limited penetration of the optical signal. These results were confirmed by ex vivo histology-based studies which showed that the combination of both RF-IVUS and OCT permits more accurate identification of high-risk plaques. 3, 4 In another study, Gonzalo et al. focused on bifurcation lesions and used the origin of side branches as matching anatomical landmarks between IVUS and OCT. 5 The authors developed a methodology that takes into consideration plaque characteristics identified in both IVUS and OCT images to define the phenotype of the plaque and found that high-risk plaques with a thin fibrous cap are seen more often at the proximal rim of the bifurcation. The same research group implemented serial combined IVUS-OCT imaging in 24 patients to study bifurcation lesions and found no difference in the fibrous cap thickness and necrotic core after 6 months follow-up. 6 These findings contradict a previous RF-IVUS-based study, which showed that the phenotype of the plaque rapidly changes with time with high-risks plaques regressing to stable forms and stable lesions progressing to high risk phenotypes. 7 Recently, Tian et al. evaluated plaque characteristics using combined IVUS-OCT imaging in lesions with various degrees of severity and found that lesions with significant luminal stenoses (>70% diameter stenosis) had an increased plaque burden, were more often TCFAs, and exhibited neo-vessels and cholesterol crystals more frequently than the lesions with a mild (30-49%) or moderate stenosis (50-69%). 8 In another study, the same research group used IVUS and OCT to investigate plaque characteristics of lesions that rupture and cause cardiovascular events. 10 One hundred and twenty six plaques with a TCFA phenotype (49 ruptured plaques that caused an event, 19 ruptured plaques that did not cause an event, and 58 non-ruptured plaques) in 82 patients were included in the analysis. There were no differences between the three groups in the incidence of macrophages, neo-vessels, calcifications, and cholesterols crystals. Ruptured plaques more often had thrombus, and a thinner fibrous cap compared to the non-ruptured TCFA. Ruptured plaques that caused an event had a smaller luminal area and increased plaque burden compared to the plaques that ruptured and did not cause an event. OCT-derived plaque characteristics and in particular cap thickness had higher predictive value for ruptured plaques, whilst the plaque burden assessed by IVUS had higher predictability to ruptured plaques which caused events ( Figure 2 ). The findings of this study demonstrated the value of combined imaging in identifying lesions that are prone to progress, rupture and cause cardiovascular events, and questioned the argument that intravascular imaging cannot differentiate lesions that will silently rupture from those that will cause an event.
Moreover, a recent report used combined IVUS-OCT imaging to compare plaque characteristics in 133 patients admitted with an ACS because of plaque rupture and plaque erosion. 11 Ruptured plaques had increased plaque burden and necrotic core component, exhibited more often positive remodelling, had a TCFA phenotype and were located either proximally or distally to the minimum lumen area site. On the other hand, lesions with plaque erosion had more often negative remodelling, exhibited modest plaque burden, were fibrotic-rich and half of the them were located proximally to the minimum lumen area site, a quarter of them in the minimum lumen area site and another quarter distally to the minimum lumen area site. These findings indicate the different patho-biological mechanisms involved in formation and destabilization of plaques that will erode from those that determine the natural evolution of plaques that will rupture and cause cardiovascular events. Three prospective studies used combined IVUS and OCT imaging to examine the effect of statin therapy on the compositional characteristics of the plaque, with the Integrated Biomarkers Imaging Study 4 (IBIS 4), being the largest study of its kind (see Supplementary data online, Table S1 ). IBIS 4 used combined 3-vessel RF-IVUS and OCT imaging to assess plaque morphology and characteristics in patients with a ST-elevation myocardial infarction (STEMI). 12 follow-up (-0.9%, P = 0.007). 13 OCT and RF-IVUS imaging was feasible in the vast majority of the cases at both baseline (OCT: 89.9%, RF-IVUS: 85.7%) and follow-up (OCT: 86.6%, RF-IVUS: 84.8%). The complications rates were low: 1.9% at baseline and 1.1% at follow-up. When the authors compared outcomes between patients who had PCI with and without multimodality intravascular imaging they found no difference in the incidence of acute kidney injury (1.0% vs. 1.9%, P = 0.72), or the incidence of major adverse cardiovascular events after 2 years follow-up (16.7% vs. 13.3%, P = 0.39). Considering that the advancement of the IVUS or OCT catheters could cause endothelial injury, the authors compared the incidence of revascularization in the non-infracted arteries and found no statistical differences between patients who had intravascular imaging compared to those who had not (9.0% vs. 4.8%, P = 0.20). These findings suggest that multimodality intravascular imaging is feasible and safe, even in highrisk patients treated for STEMI.
Intravascular ultrasound-near infrared spectroscopic imaging
The first IVUS-NIRS studies focused on the comparison of RF-IVUS and NIRS in assessing the composition of the plaque and demonstrated a weak correlation in the estimation of the two modalities with regards to the lipid burden. 14, 15 Similar were the findings of a small scale study that compared NIRS and OCT. 16 These discrepancies between different imaging modalities are due to the limitations of each modality and underscore the potential additive value of multimodality imaging for more accurate plaque characterization. This hypothesis was confirmed by histology-based studies which showed that combined IVUS-NIRS imaging allows more accurate identification of high-risk, vulnerable plaques. 17, 18 The Reduction in Yellow Plaque by Intensive Lipid Lowering Therapy (YELLOW) was the first study that used combined IVUS and NIRS imaging to assess the effect of aggressive lipid lowering treatment in flow limiting lesions. 19 In this study, IVUS and NIRS imaging was performed at baseline and at 7 weeks follow-up in lesions with a fractional flow reserve <0.80 in 87 patients who were randomized to aggressive or standard of care lipid therapy. Anatomical landmarks and angiographic images were used to co-register the IVUS and the NIRS data acquired at the two time points. Within 2 months there was a 24% reduction in the lipid component and an increase in the elastic membrane area by 9% in the intensive treatment group, whilst in the standard of care group the change in the lipid component was increased by 5.4% and the external elastic membrane by 3%. Concerns were raised that these ambiguous results (i.e. the excessive reduction in lipid component, which was much greater than had been reported in other studies, and the increase in the outer vessel wall area) could have been caused by inaccurate co-registration of the two imaging modalities at baseline and follow-up, and highlighted the need to develop hybrid dual-probe catheters that would allow accurate coregistration of the acquired data.
20
Combined RF-IVUS and NIRS imaging was also used to assess the effect of aggressive lipid lowering treatment with rosuvastatin on the plaque burden and composition in the Integrated Biomarkers Imaging Study 3 (IBIS 3) which included 164 patients who underwent coronary angiography for clinical purposes and had serial single vessel RF-IVUS imaging at baseline and 6 or 12 months follow-up. 21 One hundred three of these patients also had serial NIRS imaging. In contrast to the YELLOW study, IBIS failed to demonstrate a treatment effect on the lipid component and there was an increase in the percentage atheroma volume at follow-up (see Supplementary data online, Table S1 ).
Further information about the implications of lipid lowering treatment on plaque characteristics are expected to be provided by the .Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid Lowering (YELLOW II) study which is actively enrolling patients with lipid rich lesions that will have serial IVUS-NIRS and OCT imaging at baseline and 8-12 weeks follow-up (NCT01837823).
Hybrid intravascular imaging: first human studies of dual-probe catheters
The miniaturization of medical devices and advances in imaging processing has enabled the construction of dual-probe catheters which and with plaques that ruptured and cause an cardiovascular event. Table 1 and Table 2 provides the cut-off, the Youden index, the sensitivity, specificity, the positive and the negative predictive value of the plaque characteristics that differentiate ruptured from non-ruptured TCFA and of the variables that differentiate the culprit from the non-culprit ruptured TCFA, respectively. Images were obtained and modified with permission from Tian et al.
provide comprehensive visualization and complete assessment of plaque pathophysiology. Several prototypes are currently under development including the combined IVUS-OCT, NIRS-OCT, IVUS-near infrared fluorescence (NIRF), IVUS-photoacoustics and IVUSfluorescence lifetime imaging and have recently been tested in histology studies and animal studies providing promising results ( Figure 3 ). However technical limitations (i.e. relatively large catheters, poor imaging quality, increased time for data acquisition, need for blood removal) have not allowed their application in the clinical arena yet. 1 Today two catheters, the combined NIRS-IVUS and the OCT-NIRF have been used in the clinical setting (see Supplementary data online, Table S2 ).
Hybrid near infrared spectroscopyintravascular ultrasound catheter
The NIRS-IVUS catheter (TVC, InfraReDx, Inc., Burlington, Massachusetts) incorporates a rotational IVUS transducer with a NIRS probe on a single 3.2Fr catheter and provides cross sectional images of the coronary arteries where the IVUS and NIRS information is co-registered allowing assessment of the lumen and outer vessel wall morphology, and evaluation of plaque distribution and composition. The catheter is commercially available and has received FDA approval for the study of the composition of the plaque. Several reports used this modality to assess plaque characteristics and vulnerability. Roleder et al. used OCT as gold standard to assess the efficacy of NIRS-IVUS in evaluating plaque phenotype and demonstrated that combined NIRS-IVUS imaging allows detection of OCT-derived TCFA with a high sensitivity and specificity (100% and 91%, respectively). 22 A limitation of this analysis however, was the fact that the authors used OCT as a reference instead of using the information by all the three imaging modalities to more accurately characterize plaque morphology. 20 Madder et al. used NIRS-IVUS to assess plaque characteristics in 20 patients admitted with STEMI and showed that culprit lesions have specific morphological characteristics i.e. an increased plaque burden and lipid component that allow their differentiation from the non-culprit lesions with a high accuracy [area under the curve (AUC): 0.90]. 23 A larger scale, two centre study including 75 patients admitted with a STEMI has confirmed the above findings demonstrating that the maximum lipid plaque burden index in a 4 mm segment was able to differentiate culprit from the non-culprit lesions with a sensitivity and specificity of 64% and 85%, respectively. 24 The same research group has reported similar findings in patients admitted with non-STEMI and unstable angina: NIRS-IVUS imaging enabled identification of culprit lesions with high accuracy in both studied groups (AUC: 0.87 and 0.79, respectively). 25 Nevertheless, there is no prospective data today about the predictive value of the combined NIRS-IVUS imaging to detect high-risk prone to rupture plaques. To answer this questions two studies, the Prospective Natural History Study Using Multimodality Imaging in Patients With Acute Coronary Syndromes (PROSPECT II, NCT02171065) and the Lipid Rich Plaque (NCT02033694), have recently commenced and are anticipated to provide further insights about the value of hybrid-intravascular imaging in vulnerable plaque detection. Combined IVUS-NIRS-OCT imaging has also been used to evaluate the effect of sex on plaque morphology in patients with stable angina. 26 In the study of Bharadwaj et al., 128 patients (95 men and 33 women) with stable angina had combined IVUS-NIRS and OCT imaging of the culprit lesions. There were no significant differences between groups in the thickness of the fibrous cap, the incidence of TCFA, macrophage accumulation, microvessels and the calcific and lipid burden-assessed by NIRS. Male patients had an increased plaque burden compared to females but this difference was not statistically significant when patient clinical characteristics were taken into account.
Hybrid optical coherence tomographynear infrared fluorescence imaging catheter NIRF involves the injection of activatable markers that have the ability to bind molecules associated with plaque vulnerability and fluoresce when they are irradiated with near infrared light. Combined OCT-NIRF imaging provides unique opportunities for studying plaque pathophysiology as OCT is able to assess luminal dimensions and plaque morphology while NIRF-depending on the activatable marker that is used for imaging-appears able to detect molecules associated with increased inflammation such as matrix metalloproteinases or cathepsins. 27 Today two OCT-NIRF catheters are available that incorporate an OCT probe and a NIRF transducer into a dual clad catheter (diameter: 2.4-2.6Fr) that acquire 24.5-100 frames/s and are pulled-back at a constant speed by an automated pull-back device. Several experimental studies in animal models that used numerous activatable markers have provided robust evidence about the feasibility of combined OCT-NIRF imaging and showed that NIRF enables detection of macrophages accumulation and fibrin deposition 28, 29 ; but none of these markers have been used in the clinical setting yet.
In a recent report, Wang et al. showed that necrotic-rich plaques have the ability to fluoresce (near infrared autofluoresnce imaging-NIRAF) when they are excited with NIRF light at 633 nm. 30 The safety and the efficacy of OCT-NIRAF in the characterization of atherosclerosis was been tested in a small study involving 12 patients undergoing PCI. 31 The acquired NIRAF emission intensities were coregistered offline with the OCT imaging data. A strong NIRAF signal was seen in regions of plaque with high-risk features such as lipid containing plaques, thin-fibrous caps, macrophages and ruptured plaques with overlaying thrombus. The authors observed that not all the plaques with high-risk features (i.e. macrophages, lipid-rich lesions) had increased NIRAF signal and speculated that an increased NIRAF signal may be a new imaging marker associated with increased plaque vulnerability ( Figure 4) . Histological evidence has showed that NIRAF may allow detection of inflamed plaques with oxidized lipid component and neo-vessels 32 ; further research is required towards this direction in order to better understand the pathobiological implications and clinical relevance of an increased NIRAF signal.
Discussion-Conclusions
The first multimodality imaging studies of coronary atherosclerosis have provided robust evidence that multimodality intravascular imaging is feasible and enables more detailed evaluation of the composition of the plaque, more accurate characterization of its phenotype and assessment of plaque features associated with increased vulnerability. More importantly these studies eradicated false beliefs about the morphology of vulnerable plaques, furthered our understanding of plaque vulnerability and demonstrated that a complete assessment of plaque pathobiology may enable more accurate identification of the lesions that will progress, rupture and cause cardiovascular events. Finally, serial multimodality imaging studies have allowed us to better understand atherosclerotic evolution and have a complete assessment of the effect of treatments on plaque burden, morphology, and vulnerability.
However, although it is apparent that multimodality intravascular imaging is superior to standalone imaging its applications in the study of atherosclerosis is limited. This is attributed to the risk-despite being minimal-of complications, to the increased cost and time required for multimodality intracoronary imaging of the coronary arteries, as well as the fact that co-registration and analysis of the acquired data is a tedious and time consuming process. Some of these limitations are expected to be overcome by hybrid dual-probe catheters, whilst others such as the increased cost, the partial sampling of the coronary tree and the risk of complications will remain considerable pitfalls for intravascular imaging.
Today several ongoing large scale prospective hybrid-invasive imaging-based studies of coronary atherosclerosis have commenced and are expected to provide us with more information on the potential value of hybrid intravascular imaging in understanding the mechanisms involved in atherosclerotic plaque development and destabilization and in detecting lesions that are prone to progress and cause events. The advent of new hybrid imaging modalities is anticipated to provide further opportunities to study plaque pathobiology and allow reliable detection of vulnerable plaques and patients that are at high risk to sustain future cardiovascular events. Preliminary uni-modality intravascular imaging studies have provided proof of the latter concept 33 and showed that a complete assessment of coronary morphology is likely to enable more accurate risk stratification which would justify the implementation of individualized secondary prevention strategies using aggressive pharmacological or interventional treatments targeting atherosclerotic process in selected populations.
